Lupus Trial, Recruiting NCT06208514 Sponsor: University of Michigan Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT06208514
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who can read, write, and speak English
  • People who have internet access and the ability to join video or audio calls (such as Zoom) from home, either by phone or computer

For people with fibromyalgia, one of the following must apply:

  • A doctor has diagnosed the person with fibromyalgia
  • The person meets a set of standard scoring criteria for fibromyalgia based on widespread pain and symptom severity (confirm with trial site for exact scores)
  • The person reports pain in at least 4 out of 7 body regions on a specific body map, and a doctor has diagnosed them with Opioid Use Disorder

For people with lupus, all of the following must apply:

  • A doctor has diagnosed the person with systemic lupus erythematosus (a type of autoimmune disease)
  • The person reports pain in at least 4 out of 7 body regions on a specific body map
  • The person's medications and steroid doses have not changed in the month before joining the trial

For people with chronic low back pain, both of the following must apply:

  • The person has had low back pain on at least half the days over the past 6 months
  • Over the past 7 days, the person's average pain level has been at least 4 out of 10

Who may not be able to join:

  • People whose chronic pain is thought to be caused by another condition (such as inflammatory arthritis, other autoimmune disorders, spinal cord injury, or cancer)
  • People who are currently receiving cognitive-behavioural therapy or other psychological treatments for pain
  • People who have had open legal proceedings related to their chronic pain within the past year
  • People whose ability to understand and complete study procedures is in question, as assessed by study staff during the consent process
  • People who are pregnant or breastfeeding
  • People with other diseases or conditions that the trial's lead investigators determine would make participation unsuitable
  • For lupus participants only: People taking more than 10 mg of prednisone (or an equivalent steroid medication) per day
  • For chronic pelvic pain participants only: People who have had surgery for a chronic pelvic pain condition within the past 6 months
  • For chronic low back pain participants only: People who have a back surgery scheduled, or whose leg pain is greater than their back pain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: John Sturgeon, PhD, University of Michigan

Phone: 734-998-5837

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 March 2024
Est. completion
1 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in pain intensity based on the Numeric Pain Rating Scale between day 1 (T1) and day 60 (T5)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov